Axon (AXON) director trades 564 shares and is granted 611 RSUs

Q: What insider transactions did Axon (AXON) director Caitlin Kalinowski report?

Caitlin Kalinowski reported both a sale and a grant. She sold 564 shares of Axon common stock in multiple open-market transactions on June 1, 2026, and received 611 time-vested restricted stock units on May 29, 2026, as equity compensation.

Q: How many Axon (AXON) shares did the director sell and at what prices?

The director sold 564 Axon common shares. The sales occurred in several open-market trades on June 1, 2026, at prices that include $484.11 and $473.32 per share, with weighted-average prices disclosed for trades executed in ranges.

Q: What Axon (AXON) equity award did Caitlin Kalinowski receive?

She received 611 restricted stock units. The grant was made on May 29, 2026, under Axon’s Amended and Restated 2022 Stock Incentive Plan and is scheduled to vest fully on the earlier of the one-year anniversary of grant and the 2027 annual meeting.

Q: Were Axon (AXON) director sales executed in a single trade or multiple trades?

The reported sales were executed in multiple trades. Footnotes explain that several transactions occurred within price ranges, with the Form 4 reporting weighted-average sales prices and offering to provide detailed trade breakdowns upon request.

Filing Impact

(Moderate)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

AXON ENTERPRISE, INC. director Caitlin Elizabeth Kalinowski reported mixed equity activity. On June 1, 2026, she completed a series of open-market sales totaling 564 shares of Axon common stock at prices including $484.11 and $473.32 per share, leaving her with 3,632 shares held directly. Earlier, on May 29, 2026, she received a grant of 611 time-vested restricted stock units under Axon’s Amended and Restated 2022 Stock Incentive Plan, scheduled to vest in full on the earlier of the one-year anniversary of the grant date and the company’s 2027 annual meeting of shareholders.

Insider Trade Summary

Net Seller: 564 shares ($270,140)

Net Sell 9 txns

Insider Kalinowski Caitlin Elizabeth

Role null

Sold 564 shs ($270K)

Type	Security	Shares	Price	Value
Sale	Common Stock	40	$473.32	$19K
Sale	Common Stock	80	$475.185	$38K
Sale	Common Stock	84	$476.2662	$40K
Sale	Common Stock	80	$477.385	$38K
Sale	Common Stock	40	$478.51	$19K
Sale	Common Stock	40	$480.55	$19K
Sale	Common Stock	160	$482.93	$77K
Sale	Common Stock	40	$484.11	$19K
Grant/Award	Common Stock	611	$0.00	--

Holdings After Transaction: Common Stock — 4,156 shares (Direct, null)

Footnotes (1)

Time-vested restricted stock units granted to the reporting person pursuant to the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan. The award is scheduled to vest in full on the earlier of the one-year anniversary of the grant date and the date of Axon Enterprise, Inc.'s 2027 Annual Meeting of Shareholders. The transaction was executed in multiple trades at prices ranging from $474.97 to $475.40. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The transaction was executed in multiple trades at prices ranging from $476.00 to $476.51. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The transaction was executed in multiple trades at prices ranging from $477.10 to $477.67. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The transaction was executed in multiple trades at prices ranging from $482.38 to $483.36. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Key Figures

Shares sold: 564 shares Sale price example (high): $484.11 per share Sale price example (low): $473.32 per share +3 more

6 metrics

Shares sold 564 shares Total open-market sales on June 1, 2026

Sale price example (high) $484.11 per share One of the reported Axon common stock sale prices

Sale price example (low) $473.32 per share One of the reported Axon common stock sale prices

RSUs granted 611 units Grant on May 29, 2026 under 2022 Stock Incentive Plan

Shares held after sales 3,632 shares Common stock owned directly after June 1, 2026 transactions

Net share direction net-sell of 564 shares Transaction summary across reported non-derivative trades

Key Terms

restricted stock units, Amended and Restated 2022 Stock Incentive Plan, weighted average sales price, open market or private transaction, +1 more

5 terms

restricted stock units financial

"Time-vested restricted stock units granted to the reporting person pursuant to the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Amended and Restated 2022 Stock Incentive Plan financial

"Time-vested restricted stock units granted to the reporting person pursuant to the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan."

weighted average sales price financial

"The price reported above reflects the weighted average sales price."

open market or private transaction financial

"Sale in open market or private transaction"

Annual Meeting of Shareholders regulatory

"the date of Axon Enterprise, Inc.'s 2027 Annual Meeting of Shareholders."

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

06/02/2026 - 05:23 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kalinowski Caitlin Elizabeth

(Last)

(First)

(Middle)

17800 NORTH 85TH STREET

(Street)

SCOTTSDALE

ARIZONA

85255

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AXON ENTERPRISE, INC. [ AXON ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/29/2026		A		611⁽¹⁾	A	$0	4,196	D
Common Stock	06/01/2026		S		40	D	$473.32	4,156	D
Common Stock	06/01/2026		S		80⁽²⁾	D	$475.185	4,076	D
Common Stock	06/01/2026		S		84⁽³⁾	D	$476.2662	3,992	D
Common Stock	06/01/2026		S		80⁽⁴⁾	D	$477.385	3,912	D
Common Stock	06/01/2026		S		40	D	$478.51	3,872	D
Common Stock	06/01/2026		S		40	D	$480.55	3,832	D
Common Stock	06/01/2026		S		160⁽⁵⁾	D	$482.93	3,672	D
Common Stock	06/01/2026		S		40	D	$484.11	3,632	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Time-vested restricted stock units granted to the reporting person pursuant to the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan. The award is scheduled to vest in full on the earlier of the one-year anniversary of the grant date and the date of Axon Enterprise, Inc.'s 2027 Annual Meeting of Shareholders.

2. The transaction was executed in multiple trades at prices ranging from $474.97 to $475.40. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

3. The transaction was executed in multiple trades at prices ranging from $476.00 to $476.51. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

4. The transaction was executed in multiple trades at prices ranging from $477.10 to $477.67. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

5. The transaction was executed in multiple trades at prices ranging from $482.38 to $483.36. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

	/s/ Caitlin E. Kalinowski by Isaiah Fields, Attorney-in-Fact	06/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did Axon (AXON) director Caitlin Kalinowski report?

Caitlin Kalinowski reported both a sale and a grant. She sold 564 shares of Axon common stock in multiple open-market transactions on June 1, 2026, and received 611 time-vested restricted stock units on May 29, 2026, as equity compensation.

How many Axon (AXON) shares did the director sell and at what prices?

The director sold 564 Axon common shares. The sales occurred in several open-market trades on June 1, 2026, at prices that include $484.11 and $473.32 per share, with weighted-average prices disclosed for trades executed in ranges.

What Axon (AXON) equity award did Caitlin Kalinowski receive?

She received 611 restricted stock units. The grant was made on May 29, 2026, under Axon’s Amended and Restated 2022 Stock Incentive Plan and is scheduled to vest fully on the earlier of the one-year anniversary of grant and the 2027 annual meeting.

How many Axon (AXON) shares does the director hold after these transactions?

Post-transaction, the director holds 3,632 shares directly. This figure reflects her Axon common stock ownership immediately following the reported open-market sales on June 1, 2026, as disclosed in the Form 4 filing.

Were Axon (AXON) director sales executed in a single trade or multiple trades?

The reported sales were executed in multiple trades. Footnotes explain that several transactions occurred within price ranges, with the Form 4 reporting weighted-average sales prices and offering to provide detailed trade breakdowns upon request.